Why choose QIAseq Multimodal technology?
Recent advances in NGS and bioinformatics have empowered researchers to simultaneously sequence DNA and RNA from biological samples. However, current approaches require two separate workflows for DNA and RNA library preps, which call for higher input materials, longer turnaround times and increased costs .
One sample, flexible options—to accelerate your multiomic studies
With QIAseq Multimodal technology, you can take a whole-omics approach (whole genome and whole transcriptome) or a targeted approach by amplicon- or hybrid capture-based enrichment, to examine DNA and RNA analytes. The automation-friendly workflows enable simultaneous profiling of DNA and RNA biomarkers from a single sample to accelerate your multiomic studies. Moreover, QIAseq Multimodal chemistries facilitate reliable and sensitive detection of variants from a diverse array of sample types and require as little as 10 ng of input.
Multimodal sequencing
Custom design
Comprehensive genomic profiling
Comprehensive genomic profiling (CGP) is dramatically changing our understanding of various cancers, revealing an unprecedented level of detail. Multimodal sequencing can accelerate this rapidly evolving field of research.
Top 3 reasons to adopt a multimodal approach for CGP:
- Save time and resources: Consolidate separate workflows into a single-day, sample to sequencing workflow.
- Conserve precious samples: Simultaneously profile multiple DNA and RNA biomarkers, TMB and MSI from a single, low-input sample.
- Get deeper insights: Achieve a holistic view of various DNA and RNA biomarkers efficiently.
What can you profile with the QIAseq Pan-cancer Multimodal Panel?
Explore the QIAseq Pan-cancer Multimodal Panel
Sample prep
Watch the on-demand webinars
-
Introducing a consolidated workflow for DNA and RNA library preparation from a single sample
In this webinar, we introduce the QIAseq Multimodal DNA/RNA Library Kit, which helps you prepare DNA and RNA libraries from a single sample. The kit is compatible with most starting materials and can easily be adapted to your preferred sequencing breadth – from WGS/WTS to targeted sequencing.
-
Evolution of tumor profiling in a clinical lab: Moving toward comprehensive genomic profiling
In this webinar, Vincent Funari of NeoGenomics discusses how his team has evolved its profiling approaches for both heme and solid tumors from targeted panels to more comprehensive genomic profiling.
-
Comprehensive genomic profiling of solid tumors and heme malignancies
In this webinar, we discuss how you can uncover insights into multiple cancers from just 1 ng total nucleic acid using the QIAseq Pan-cancer Multimodal Panel. Learn about the technology and how it can ensure superior coverage while saving time and costs.
-
One-day workflow for simultaneous profiling of DNA variants and RNA fusions
In this webinar, we explore a new workflow for simultaneous NGS profiling of both DNA variants and RNA fusions, as well as gene expression in just one day, using as little as 10 ng sample.
-
Analyzing multimodal data with QIAGEN CLC Genomics Workbench
In this webinar, we will take you through an introduction and live demo of the QIAGEN CLC Genomics Workbench workflow for multimodal analysis. Discover this intuitive yet powerful solution tailored for analysis of NGS data generated with QIAseq Multimodal Panels.
-
Introducing a consolidated workflow for DNA and RNA library preparation from a single sample
-
Evolution of tumor profiling in a clinical lab: Moving toward comprehensive genomic profiling
-
Comprehensive genomic profiling of solid tumors and heme malignancies
-
One-day workflow for simultaneous profiling of DNA variants and RNA fusions
-
Analyzing multimodal data with QIAGEN CLC Genomics Workbench